-
Similar sounding drug names should come with warningsBy Dr Ananya Mandal, MD There have been mix ups and medication errors with similar sounding names of drugs - eye drops called Durezol and salicylic acid-containing wart remedy Duresal for example.2012/1/4
-
Drug shortages dominate 2011 headlinesAsk average consumers to identify the biggest trend in pharmaceuticals, and they'd likely come back with one word: Shortages. Supply problems affected everything from oncology drugs to anesthetics. Th2011/12/26
-
European crisis crimps pharma's financesWhile European leaders wrangled, wailed and gnashed their teeth about the sovereign debt crisis, drugmakers were feeling their own pain. Hospitals in Greece, Spain, Portugal and Italy stopped paying t2011/12/26
-
Drugmaker Merck to pay $24M to settle Medicaid caseThe drugmaker has agreed to settle a civil lawsuit that accused a former subsidiary of overpaying pharmacists for a widely used medication. The Associated Press/Washington Post: Drugmaker Merck Agr2011/12/23
-
AstraZeneca’s Faslodex given final snub by NICEThe UK's National Institute for Health and Clinical Excellence (NICE) has snubbed AstraZeneca breast cancer drug Faslodex in its final guidance, deeming it an inefficient use of NHS resources.NICE det2011/12/23
-
Drug makers eye small citiesCountry's health reforms open doors to foreign healthcare firms BEIJING / SHANGHAI - As reform of China's medical care system makes its way down to some of the smaller cities in China, multinatio2011/12/22
-
National Food and Drug Regulatory Working Conference held in BeijingThe 2012 National Food and Drug Regulatory Working Conference was held in Beijing on December 20, 2011. Li Keqiang, Vice Premier of the State Council, made important instructions for the conference. H2011/12/22
-
Glaxosmithkline in Montrose has been awarded a £1.46 million Research and Development grant from Scottish EnterpriseFinance Secretary John Swinney gave details of the investment on a tour of the Montrose facility today where he met some of the key staff who will be working on new research and development projects.T2011/12/21
-
AstraZeneca hit by further drug development disappointmentUK-based pharmaceutical firm AstraZeneca has been hit by further disappointments in its drug development efforts, announcing a $381.5m charge in the fourth quarter following poor results from two new2011/12/21
-
Fluoride supplements not found to be safe or effectiveAccording to the Cochrane Oral Health Group, fluoride supplements fail to reduce tooth decay in primary teeth, permanent teeth cavity-reduction is dubious and health risks are little studied. Further,2011/12/20